Opthea Limited has released a press release.
Results of Meeting
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Opthea
- Opthea Files Registration Statement for Proposed US IPO
- Opthea Full Year Financial Report 2020
- Opthea Announces Plans for Potential US listing and IPO
- Opthea Completes Successful FDA and EMA Meetings for Phase 3
- Corporate Presentation of Ph1b/2a DME Trial Data (ASRS)
Later from Opthea
- Opthea Launches Proposed US Initial Public Offering
- Opthea Announces Pricing of US Initial Public Offering
- Opthea Announces Closing of US Initial Public Offering
- Opthea Receives A$8.5m R&D Tax Incentive
- Opthea Finalizes Ph 3 Study Designs and Startup Activities
Follow Opthea into a list and get an email when it puts out news.
Follow Opthea